The anti-inflammatory drug celecoxib, known by the brand name Celebrex, triggers liver cancer cell death by reacting with a protein in a way that makes those cells commit suicide, according to a new study. Researchers also found that the combination … Continue reading |
|
The post Liver cancer cells killed by Celebrex: OSU study appeared first on Health, Medical, and Science Updates.